EUS for portal hypertension: a comprehensive and critical appraisal of clinical and experimental indications
Mohamed Elsaadany(Mansoura University), Manisha Bhutani(Carolinas Healthcare System), Hiromasa Ohira(Fukushima Medical University), Atushi Irisawa(Fukushima Medical University), Sajid Jalil(The University of Texas Medical Branch at Galveston), Goro Shibukawa(Fukushima Medical University)
Cited by 37
Related Papers
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
|JAMA Oncology|2015|309
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272